Thalamotomy for the alleviation of levodopa-induced dyskinesia: Experimental studies in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated parkinsonian monkey

Neuroscience

Volumn 55, Issue 1, 1993, Pages 147-165

  Page, R D ^a   Sambrook, M A ^a   Crossman, A R ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; APOMORPHINE; CARBIDOPA; CARBIDOPA PLUS LEVODOPA; LEVODOPA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; DRUG MIXTURE; DYSKINESIA; DYSTONIA; HISTOLOGY; MONKEY; NONHUMAN; ORAL DRUG ADMINISTRATION; PARKINSON DISEASE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THALAMOTOMY;

AFFERENT PATHWAYS; ANIMAL; APOMORPHINE; AXONAL TRANSPORT; BRAIN MAPPING; CHOREA; DYSKINESIA, DRUG-INDUCED; DYSTONIA; GLOBUS PALLIDUS; HORSERADISH PEROXIDASE; LEVODOPA; MACACA FASCICULARIS; MPTP POISONING; PARKINSON DISEASE, SECONDARY; STEREOTAXIC TECHNIQUES; SUPPORT, NON-U.S. GOV'T; THALAMUS; WHEAT GERM AGGLUTININS;

EID: 0027286045     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(93)90462-O     Document Type: Article

References (45)

1. Stereotaxic thalamotomy in 55 cases of dystonia
2. Cytoarchitectonic deliniation of the ventral lateral thalamic region in the monkey
3. Distribution of cerebellar terminations and their relation to other afferent terminations in the ventral lateral thalamic region of the monkey
4. Anatomical evidence for segregated focal groupings of efferent cells and their terminal ramifications in the cerebellothalamic pathway of the monkey
5. A primate model of Parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
6. Levodopa-induced dyskinesia and response fluctuations in primates rendered Parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
7. 20 Year follow up of the neurosurgical treatment of dystonia musculorum deformans
8. Guide to radiofrequency lesion generation in neurosurgery
9. Aromatic amino acids and modification of Parkinsonism
10. A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: implications for future strategies in treatment
11. Experimental hemichorea/ballismus in the monkey: studies on the intracerebral site of action in a drug-induced dyskinesia
12. Chronic Parkinsonism secondary to intravenous injection of meperidine analogues
13. The afferent connections of the main and the accessory olfactory bulb formations in the rat: an experimental HRP study
14. An autoradiographic study of the efferent connections of the globus pallidus inMacaca mulatta
15. Systemic therapy of dystonia
16. A sensitive low artifact TMB procedure for the demonstration of WGA-HRP in the CNS
17. Pallidal neurons branching to the thalamus and to the midbrain in the monkey
18. Cell sparse zones in the ventrolateral thalamic mass in humans, monkeys and cats: their special reference to kinesthetic neurons
19. Parkinsonism: onset progression and mortality
20. Organisation of the nigrothalamocortical system in the rhesus monkey
21. Sagittal cytoarchitectonic maps of theMacaca mulatta thalamus with a revised nomenclature of the motor-related nuclei validated by observations on their connectivity
22. Basal ganglia and other afferent projections to the peribrachial region in the rat: a study using retrograde and anterograde transport of horseradish peroxidase
23. Correlation and revised nomenclature of ventral nuclei in the thalamus of human and monkey
24. Pedunculopontine tegmental nucleus-induced inhibition of muscle activity in the rat
25. Contemporary methods for stereotactic ventralis lateralis thalamotomy and for the stereotactic biopsy of intracranial neoplasms
26. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis
27. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): implications for treatment and the pathogenesis of Parkinson's disease
28. L-dopa or bromocriptine for Parkinson's disease: which, how much and when?
29. Neural mechanisms underlying Parkinsonism symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
30. Topographic projections from the basal ganglia to the nucleus tegmenti pedunculopontinus pars compacta of the cat with special reference to pallidal projections
31. Possible role of cerebellar circuits in Parkinsonian symptoms
32. Projections of the lentiform nucleus in the monkey
33. Physiological study of presumed ventralis intermedius neurons in the human thalamus
34. A new stabilizing agent for the tetramethyl benzidine (TMB) reaction product in the histochemical detection of horseradish peroxidase (HRP)
35. The pallidointralaminar and pallidonigral projections in primate as studied by retrograde double labelling method
36. The thalamic territory of cerebellar afferents and the lateral region of the thalamus of the Macaque in stereotaxic ventricular co-ordinates
37. The centre median and parafascicular thalamic nuclei project respectively to the sensorimotor and associative-limbic striatal territories in the squirrel monkey
38. Thalamic relay to motor cortex: afferent pathways from brainstem, cerebellum and spinal cord in monkeys